ACE Inhibitors, Beta-Blockers Could Mediate Trastuzumab Cardiac Toxicity

In patients with HER2-positive breast cancer undergoing trastuzumab therapy, the use of an ACE inhibitor or beta-blocker could protect against cardiac toxicity.

Source: CancerNetwork - December 1, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer Cancer Complications HER2-Positive Breast Cancer News Source Type: news